Study on the mechanism of lupenone for treating type 2 diabetes by integrating pharmacological evaluation and network pharmacology

• Ngā kaituhi matua: Feng Xu (Author), Mei Zhang (Author), Hongmei Wu (Author), Yuanmin Wang (Author), Ye Yang (Author), Xiangpei Wang (Author)
• Hōputu: Pukapuka
• I whakaputaina: Taylor & Francis Group, 2022-12-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Context Lupenone (LUP) is the active ingredient of Musa basjoo Sieb. et Zucc. (Musaceae) with antidiabetes effects, but an unclear underlying mechanism of action.Objective Animal experiments combined with network pharmacology were used to explore the mechanism of LUP for treating diabetes.Materials...